42 related articles for article (PubMed ID: 15056642)
1. Clinically Compatible Fluorescence Microscopy Based on Moxifloxacin Antibiotic.
Lee S; Kim KH
Adv Exp Med Biol; 2021; 1310():91-113. PubMed ID: 33834434
[TBL] [Abstract][Full Text] [Related]
2. Impact of Antibiotic Gut Exposure on the Temporal Changes in Microbiome Diversity.
Burdet C; Nguyen TT; Duval X; Ferreira S; Andremont A; Guedj J; Mentré F;
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31307985
[TBL] [Abstract][Full Text] [Related]
3. Two-photon microscopy of Paneth cells in the small intestine of live mice.
Jang WH; Park A; Wang T; Kim CJ; Chang H; Yang BG; Kim MJ; Myung SJ; Im SH; Jang MH; Kim YM; Kim KH
Sci Rep; 2018 Sep; 8(1):14174. PubMed ID: 30242205
[TBL] [Abstract][Full Text] [Related]
4. Moxifloxacin: Clinically compatible contrast agent for multiphoton imaging.
Wang T; Jang WH; Lee S; Yoon CJ; Lee JH; Kim B; Hwang S; Hong CP; Yoon Y; Lee G; Le VH; Bok S; Ahn GO; Lee J; Gho YS; Chung E; Kim S; Jang MH; Myung SJ; Kim MJ; So PT; Kim KH
Sci Rep; 2016 Jun; 6():27142. PubMed ID: 27283889
[TBL] [Abstract][Full Text] [Related]
5. Gender analysis of moxifloxacin clinical trials.
Chilet-Rosell E; Ruiz-Cantero MT; Pardo MA
J Womens Health (Larchmt); 2014 Jan; 23(1):77-104. PubMed ID: 24180298
[TBL] [Abstract][Full Text] [Related]
6. Essentials for selecting antimicrobial therapy for intra-abdominal infections.
Blot S; De Waele JJ; Vogelaers D
Drugs; 2012 Apr; 72(6):e17-32. PubMed ID: 22480338
[TBL] [Abstract][Full Text] [Related]
7. Canadian practice guidelines for surgical intra-abdominal infections.
Chow AW; Evans GA; Nathens AB; Ball CG; Hansen G; Harding GK; Kirkpatrick AW; Weiss K; Zhanel GG
Can J Infect Dis Med Microbiol; 2010; 21(1):11-37. PubMed ID: 21358883
[No Abstract] [Full Text] [Related]
8. Pharmacokinetics and penetration of moxifloxacin into infected diabetic foot tissue in a large diabetic patient cohort.
Majcher-Peszynska J; Sass M; Schipper S; Czaika V; Gussmann A; Lobmann R; Mundkowski RG; Luebbert C; Kujath P; Ruf BR; Koch H; Schareck W; Klar E; Drewelow B;
Eur J Clin Pharmacol; 2011 Feb; 67(2):135-42. PubMed ID: 20871984
[TBL] [Abstract][Full Text] [Related]
9. Defining the role of macrophages in local moxifloxacin tissue concentrations using biopsy data and whole-body physiologically based pharmacokinetic modelling.
Edginton AN; Ahr G; Willmann S; Stass H
Clin Pharmacokinet; 2009; 48(3):181-7. PubMed ID: 19385711
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and tissue penetration of moxifloxacin in intervention therapy for intra-abdominal abscess.
Rink AD; Stass H; Delesen H; Kubitza D; Vestweber KH
Clin Drug Investig; 2008; 28(2):71-9. PubMed ID: 18211115
[TBL] [Abstract][Full Text] [Related]
11. Occurrence of enterotoxigenic and nonenterotoxigenic Bacteroides fragilis in calves and evaluation of their antimicrobial susceptibility.
Almeida FS; Nakano V; Avila-Campos MJ
FEMS Microbiol Lett; 2007 Jul; 272(1):15-21. PubMed ID: 17488333
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections.
Malangoni MA; Song J; Herrington J; Choudhri S; Pertel P
Ann Surg; 2006 Aug; 244(2):204-11. PubMed ID: 16858182
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of moxifloxacin against 923 anaerobes isolated from human intra-abdominal infections.
Goldstein EJ; Citron DM; Warren YA; Tyrrell KL; Merriam CV; Fernandez H
Antimicrob Agents Chemother; 2006 Jan; 50(1):148-55. PubMed ID: 16377680
[TBL] [Abstract][Full Text] [Related]
14. Retrospective analysis of the safety profile of oral moxifloxacin in elderly patients enrolled in clinical trials.
Andriole VT; Haverstock DC; Choudhri SH
Drug Saf; 2005; 28(5):443-52. PubMed ID: 15853445
[TBL] [Abstract][Full Text] [Related]
15. Moxifloxacin penetration into human gastrointestinal tissues.
Wirtz M; Kleeff J; Swoboda S; Halaceli I; Geiss HK; Hoppe-Tichy T; Büchler MW; Friess H
J Antimicrob Chemother; 2004 May; 53(5):875-7. PubMed ID: 15056642
[TBL] [Abstract][Full Text] [Related]
16. Penetration of moxifloxacin into the human pancreas following a single intravenous or oral dose.
Wacke R; Förster S; Adam U; Mundkowski RG; Klar E; Hopt UT; Drewelow B
J Antimicrob Chemother; 2006 Nov; 58(5):994-9. PubMed ID: 16956903
[TBL] [Abstract][Full Text] [Related]
17. Tissue penetration of moxifloxacin into human gallbladder wall in patients with biliary tract infections.
Ober MC; Hoppe-Tichy T; Köninger J; Schunter O; Sonntag HG; Weigand MA; Encke J; Gutt C; Swoboda S
J Antimicrob Chemother; 2009 Nov; 64(5):1091-5. PubMed ID: 19734170
[TBL] [Abstract][Full Text] [Related]
18. Penetration of moxifloxacin into sternal bone of patients undergoing routine cardiopulmonary bypass surgery.
Metallidis S; Charokopos N; Nikolaidis J; Alexiadou E; Lazaraki G; Koumentaki E; Tsona A; Theodoridis G; Nikolaidis P
Int J Antimicrob Agents; 2006 Nov; 28(5):428-32. PubMed ID: 17034992
[TBL] [Abstract][Full Text] [Related]
19. Evidence-based review of moxifloxacin.
O'Brien TP
Int Ophthalmol Clin; 2006; 46(4):61-72. PubMed ID: 17060792
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
